Market Overview

Social Media Outlook for Monday June 25 (TEVA, MNTA, BMY, XOM)

Related TEVA
Market Wrap For April 16: Markets Hold On To Gains On Positive Yellen Comments And Economic Data
Sterne Agee Sees Teva Pharmaceutical Outperformance Continuing
Pfizer Loses Bid to Hold Celebrex Exclusivity to '15 (Fox Business)

In recent years, traders and investors have increasingly turned to social media to discuss their investments. Now, interested parties can get a scientific look at what is being discussed on a weekly, monthly, and even hourly basis.

Provided by Social Market Analytics, here is the social media outlook for Monday, June 25.

Most Bullish

Teva Pharmaceuticals (NYSE: TEVA) shares traded up on Monday after a U.S. District Court Judge upheld the company's patent on Copaxanre, a multiple sclerosis drug.

Momenta Pharmacueticals (NASDAQ: MNTA) shares traded down early on Monday after a court ruled against the company in the decision involving Teva Pharma.

Most Bearish

Bristol-Myers Squibb (NYSE: BMY) traded down on Monday after the company's drug Eliquis failed to gain regulatory approval. Eliquis is a drug used to prevent blood clots.

Exxon Mobile (NYSE: XOM) traded down on Monday. Exxon was forced to shut down some natural gas output in the Gulf of Mexico due to Tropical Storm Debby.

Most Discussed

Apple (NASDAQ: AAPL) is frequently discussed on social media. The patent case involving Apple and Google's (NASDAQ: GOOG) Motorola Mobility unit was shut down by a federal judge.

Research in Motion (NYSE: RIMM) traded down early on Monday. Rumors circulated that the company may split into two units.

Arena Pharmaceuticals (NYSE: ARNA) is expected to receive an FDA decision on its weight loss drug lorcaserin June 27.

Facebook (NASDAQ: FB) shares traded higher most of last week. On Monday, shares traded near $32.30, still below the company's IPO price.

Google (NASDAQ: Google) traded down slightly on Monday. The company's CEO--Larry Page--will not speak publicly at the company's upcoming events, but will continue to run the company.

Interested in getting more information about stock trends on social media? Signup for the Social Market Analytics newsletter on their website.

Posted-In: Social Market AnalyticsLong Ideas News Short Ideas Previews FDA Legal IPOs Intraday Update Movers Tech Trading Ideas Best of Benzinga

 

Most Popular

Related Articles (AAPL + ARNA)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free